Skip to main content
. 2024 Mar 14;42(1):156. doi: 10.1007/s00345-024-04852-2

Fig. 2.

Fig. 2

Management steps for minimising cumulative CVD risk at ADT initiation. *Referral to cardiologists is recommended but is subject to each country’s healthcare system and resources. ADT, androgen deprivation therapy; CV, cardiovascular; CVD, cardiovascular disease; GnRH, gonadotrophin-releasing hormone; PCa, prostate cancer